Avalo Therapeutics (AVTX) Receivables - Other (2016 - 2024)
Avalo Therapeutics posted quarterly Receivables - Other of -$600000.0 for Q4 2024, down 20.0% year-on-year from -$750000.0 in Q1 2024, and down 160.12% on a QoQ basis from $998000.0 in Q3 2024.
Avalo Therapeutics (AVTX) has 9 years of Receivables - Other data on file, last reported at -$600000.0 in Q4 2024.
- For the quarter ending Q4 2024, Receivables - Other fell 20.0% year-over-year to -$600000.0; the trailing twelve-month figure through Dec 2024 stood at -$600000.0 (down 20.0% YoY), and the FY2024 full-year result was $611000.0, up 349.26% from the prior year.
- Receivables - Other for Q4 2024 stood at -$600000.0, down from $998000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $4.3 million in Q3 2020 and bottomed at -$600000.0 in Q4 2024.
- The 5-year median for Receivables - Other is $1.3 million (2022), against an average of $1.4 million.
- The widest annual swing landed in 2020, when Receivables - Other soared 1958.27%; it then tumbled 126.06% in 2023.
- A 5-year view of Receivables - Other shows it stood at $2.2 million in 2020, then jumped by 69.34% to $3.7 million in 2021, then plunged by 48.68% to $1.9 million in 2022, then sank by 126.06% to -$500000.0 in 2023, then dropped by 20.0% to -$600000.0 in 2024.
- The last three Receivables - Other figures came in at -$600000.0 (Q4 2024), $998000.0 (Q3 2024), and $33000.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -600,000.00 |
| Dec 31, 2024 | -600,000.00 |
| Sep 30, 2024 | 998,000.00 |
| Sep 30, 2024 | 998,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | -500,000.00 |
| Dec 31, 2023 | -500,000.00 |
| Sep 30, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 857,000.00 |
| Mar 31, 2023 | 857,000.00 |
| Dec 31, 2022 | 1.92 Mn |
| Dec 31, 2022 | 1.92 Mn |
| Sep 30, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 3.74 Mn |
| Dec 31, 2021 | 3.74 Mn |
| Sep 30, 2021 | 2.48 Mn |
| Sep 30, 2021 | 2.48 Mn |
| Jun 30, 2021 | 998,000.00 |
| Jun 30, 2021 | 998,000.00 |
| Mar 31, 2021 | 2.06 Mn |
| Mar 31, 2021 | 2.06 Mn |
| Dec 31, 2020 | 2.21 Mn |
| Dec 31, 2020 | 2.21 Mn |
| Sep 30, 2020 | 4.29 Mn |
| Sep 30, 2020 | 4.29 Mn |
| Jun 30, 2020 | 1.95 Mn |
| Jun 30, 2020 | 1.95 Mn |
| Mar 31, 2020 | 2.06 Mn |
| Mar 31, 2020 | 2.06 Mn |
| Dec 31, 2019 | 4.24 Mn |
| Dec 31, 2019 | 4.24 Mn |
| Sep 30, 2019 | 208,204.00 |
| Sep 30, 2019 | 208,204.00 |
| Jun 30, 2019 | 143,011.00 |
| Jun 30, 2019 | 143,011.00 |
| Mar 31, 2019 | 5.53 Mn |
| Mar 31, 2019 | 5.53 Mn |
| Dec 31, 2018 | 5.26 Mn |
| Dec 31, 2018 | 5.26 Mn |
| Sep 30, 2018 | 6.26 Mn |
| Sep 30, 2018 | 6.26 Mn |
| Jun 30, 2018 | 3.76 Mn |
| Jun 30, 2018 | 3.76 Mn |
| Mar 31, 2018 | 3.75 Mn |
| Mar 31, 2018 | 3.75 Mn |
| Dec 31, 2017 | 3.75 Mn |
| Dec 31, 2017 | 3.75 Mn |
| Sep 30, 2017 | 3.75 Mn |
| Sep 30, 2017 | 3.75 Mn |
| Jun 30, 2017 | 75,242.00 |
| Jun 30, 2017 | 75,242.00 |
| Mar 31, 2017 | 187,363.00 |
| Mar 31, 2017 | 187,363.00 |
| Sep 30, 2016 | 379,256.00 |
| Sep 30, 2016 | 379,256.00 |
| Jun 30, 2016 | 650,488.00 |
| Jun 30, 2016 | 650,488.00 |